D Allen Annis

This inventor holds 3 USPTO granted patents. Top assignees: Neogenesis Pharmaceuticals, Inc., Neogenesis, Inc., Schering Corporation. Active years: 2000-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: D Allen Annis. Retrieved from https://idiyas.com/inventor/d-allen-annis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 66.7

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 55(Granted Patents)

Company Filing History:

1 out of 1

Neogenesis Pharmaceuticals, Inc.

Years Active: 2000-2008

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7425640 - Substituted 5-carboxyamide pyrazoles and [1,2,4]triazoles as antiviral agents (2008-09-16),

2. 6581013 - Method for identifying compounds in a chemical mixture (2003-06-17),

3. 6147344 - Method for identifying compounds in a chemical mixture (2000-11-14),

Title: The Innovative Mind of D Allen Annis

Introduction: D Allen Annis is a renowned inventor based in Cambridge, MA, known for his groundbreaking contributions to various fields.

Latest Patents: D Allen Annis holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, D Allen Annis has worked with leading research institutions and companies to develop cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, D Allen Annis has collaborated with top scientists, engineers, and innovators, fostering a culture of creativity and excellence in all his projects.

Conclusion: D Allen Annis continues to push the boundaries of innovation, leaving a lasting impact on the world with his remarkable inventions and forward-thinking approach.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]